Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
108.11
(
0.60%
)
Bitcoin
76,965.91
(
-0.57%
)
News Focus
News Focus
Post# of 20689
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jmkobers

Send PM Follow Ignore
Followers 10
Posts 783
Boards Moderated 0
Alias Born 02/08/2007

jmkobers

Re: DewDiligence post# 11332

Wednesday, 03/19/2014 9:10:24 PM

Wednesday, March 19, 2014 9:10:24 PM

Post# of 20689
<<the surveyed neurologists weren’t asked how many patients they expected to switch back from thrice-weekly Copaxone to a generic version of daily (20mg) Copaxone, so the survey doesn’t inform in this regard.>>

What is your best guess regarding how this plays out?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote